Page last updated: 2024-11-01

nifedipine and Cryptogenic Fibrosing Alveolitis

nifedipine has been researched along with Cryptogenic Fibrosing Alveolitis in 1 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Huang, MX1
Tian, YJ1
Han, C1
Liu, RD1
Xie, X1
Yuan, Y1
Yang, YY1
Li, Z1
Chen, J1
Luo, HB1
Wu, Y1

Other Studies

1 other study available for nifedipine and Cryptogenic Fibrosing Alveolitis

ArticleYear
Structural Modifications of Nimodipine Lead to Novel PDE1 Inhibitors with Anti-pulmonary Fibrosis Effects.
    Journal of medicinal chemistry, 2022, 06-23, Volume: 65, Issue:12

    Topics: Animals; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 1; Idiopathic Pulmonary

2022